Pemetrexed Found Cost-Effective in Second-Line Advanced NSCLC Compared with Docetaxel & Best Supportive Care


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles